Unravelling the mechanotransduction pathways in Alzheimer’s disease

Alzheimer’s disease (AD) represents one of the most common and debilitating neurodegenerative disorders. By the end of 2040, AD patients might reach 11.2 million in the USA, around 70% higher than 2022, with severe consequences on the society. As now, we still need research to find effective methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Donnaloja, Francesca, Limonta, Emma, Mancosu, Christian, Morandi, Francesco, Boeri, Lucia, Albani, Diego, Raimondi, Manuela Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045049/
https://www.ncbi.nlm.nih.gov/pubmed/36978103
http://dx.doi.org/10.1186/s13036-023-00336-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045049/
https://www.ncbi.nlm.nih.gov/pubmed/36978103
http://dx.doi.org/10.1186/s13036-023-00336-w

Ejemplares similares